Adequan® i.m. is the ONLY FDA approved equine polysulfated glycosaminoglycan (PSGAG) for the intramuscular treatment of non-infectious degenerative joint disease (DJD) of the carpal and hock joints proven to: DIMINISH the destructive processes of degenerative joint disease, REVERSE the processes which result in the loss of cartilage components and IMPROVE overall joint function and associated lameness. Learn more at www.Adequan.com.

NBHA National Partners